Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
journalStr:"The Canadian journal of infectious diseases & medical microbiology"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Rotstein%2C+Coleman%22&type0%5B%5D=Person&op0%5B%5D=OR&filter%5B%5D=journalStr%3A%22The+Canadian+journal+of+infectious+diseases+%26+medical+microbiology%22
/vufind/Search/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Rotstein%2C+Coleman%22&type0%5B%5D=Person&op0%5B%5D=OR&filter%5B%5D=journalStr%3A%22The+Canadian+journal+of+infectious+diseases+%26+medical+microbiology%22
Search /vufind/Search2/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Rotstein%2C+Coleman%22&type0%5B%5D=Person&op0%5B%5D=OR&filter%5B%5D=journalStr%3A%22The+Canadian+journal+of+infectious+diseases+%26+medical+microbiology%22
PubPharm (8)
1
The Prospective Antifungal Therapy Alliance® registry: A two-centre Canadian experience
enthalten in:
The Canadian journal of infectious diseases & medical microbiology
| 2014
von
Haider, S.
|
Rotstein, C.
|
Horn, D.
| +2
Wird geladen...
2
AMMI CANADA GUIDELINES - Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults
enthalten in:
The Canadian journal of infectious diseases & medical microbiology
| 2008
von
Rotstein, C.
|
Evans, G.
|
Born, A.
| +6
Wird geladen...
3
Economic evaluation of voriconazole for the treatment of candidemia in Canadian adults - Candidemia is a common cause of nosocomial bloodstream infection. This study assessed the cost-effectiveness of voriconazole for the treat-ment of candidemia compared with a regimen of conventional amphotericin B (CAB) followed by fluconazole (FLU) in the treatment of non-neutropenic patients diagnosed with candidemia. The outcome variables selected in the study were the number of patients cured within 98 days, the number of patients surviving at 98 days and the number of patients avoiding toxicity. Accounting for differences in total costs and clinical outcomes, this analysis estimated an incremental cost per patient surviving at day 98 of (USD)17,739, and an incremental cost per patient avoiding toxicity of (USD)9,298. In the case of cost per patient cured, voriconazole had a higher cost than CAB-FLU. Results of the decision-analytical model provided evidence to support the cost-effectiveness of voriconazole relative to a regimen of CAB followed by FLU in the treatment of non-neutropenic patients diagnosed with candidemia in the Canadian setting.
enthalten in:
The Canadian journal of infectious diseases & medical microbiology
| 2008
von
Rotstein, C.
|
Cragin, L.
|
Laverdière, M.
| +5
Wird geladen...
4
CASE REPORT - Treatment of candiduria with micafungin: A case series
enthalten in:
The Canadian journal of infectious diseases & medical microbiology
| 2007
von
Lagrotteria, D.
|
Rotstein, C.
|
Lee, C.
Wird geladen...
5
An economic evaluation of voriconazole versus amphotericin B for the treatment of invasive aspergillosis in Canada
enthalten in:
The Canadian journal of infectious diseases & medical microbiology
| 2004
von
Rotstein, C.
|
Laverdière, M.
|
Marciniak, A.
| +1
Wird geladen...
6
ORIGINAL ARTICLE - Antimicrobial regimens prescribed by Canadian physicians for chemotherapy-induced febrile neutropenic episodes - Over the past 30 years, advances in biomedical and pharmacological technology have had a dramatic effect on the care of patients with malignancies. Improved preventive and therapeutic strategies have helped reduce the morbidity and mortality of severely immunocompromised patients. While new recommendations for the initial selection and subsequent management of empirical antibiotics for profoundly neutropenic patients has been recently updated, adherence to them has not been evaluated. This paper reports on the use of antimicrobial management in the treatment of cancer patients with chemotherapy-induced neutropenia
enthalten in:
The Canadian journal of infectious diseases & medical microbiology
| 1999
von
Laverdière, M.
|
Bow, E.
|
Rotstein, C.
| +3
Wird geladen...
7
Implementation and evaluation of a preprinted perioperative antimicrobial prophylaxis order form in a teaching hospital
enthalten in:
The Canadian journal of infectious diseases & medical microbiology
| 1998
von
Au, P.
|
Salama, S.
|
Rotstein, C.
Wird geladen...
8
Reduction in the nephrotoxicity of amphotericin B when administered in 20% intralipid
enthalten in:
The Canadian journal of infectious diseases & medical microbiology
| 1997
von
Salama, S.
|
Rotstein, C.
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: The Canadian journal of infectious diseases & medical microbiology
Medienart
8
Aufsätze
8
Gedruckte Aufsätze
Zeitschriftentitel
The Canadian journal of infectious diseases & m...
Erscheinungszeitraum
5
2000-
3
1900-1999
Erscheinungsjahr(e)
Von:
Bis:
Haven't found what you're looking for?
Wird geladen...